The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Identification of the α 2 -δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
Open accessAbstract
Neuropathic pain is a debilitating condition affecting millions of people around the world and is defined as pain that follows a lesion or dysfunction of the nervous system. This type of pain is difficult to treat, but the novel compounds pregabalin (Lyrica) and gabapentin (Neurontin) have proven clinical efficacy. Unlike traditional analgesics such as nonsteroidal antiinflammatory drugs or narcotics, these agents have no frank antiinflammatory actions and no effect on physiological pain. Although extensive preclinical studies have led to a number of suggestions, until recently their mechanism of action has not been clearly defined. Here, we describe studies on the analgesic effects of pregabalin in a mutant mouse containing a single-point mutation within the gene encoding a specific auxiliary subunit protein (α 2 -δ-1) of voltage-dependent calcium channels. The mice demonstrate normal pain phenotypes and typical responses to other analgesic drugs. We show that the mutation leads to a significant reduction in the binding affinity of pregabalin in the brain and spinal cord and the loss of its analgesic efficacy. These studies show conclusively that the analgesic actions of pregabalin are mediated through the α 2 -δ-1 subunit of voltage-gated calcium channels and establish this subunit as a therapeutic target for pain control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
FACS-optimized mutants of the green fluorescent protein (GFP)
Cormack, B. P., Valdivia, R. H., & Falkow, S. (1996) · Gene · doi:10.1016/0378-1119(95)00685-0 · Cited by 2,620
The formalin test: an evaluation of the method
Tjølsen, A., Berge, O.-G., Hunskaar, S., Rosland, J. H., & Hole, K. (1992) · Pain · doi:10.1016/0304-3959(92)90003-t · Cited by 2,428
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Self-citationA summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Self-citationPregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, K. A., Williams, M. E., & Yaksh, T. L. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01868.2001 · Cited by 616
Auxiliary subunits: essential components of the voltage-gated calcium channel complex
Arikkath, J., & Campbell, K. P. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00066-7 · Cited by 505
Treatment of Social Phobia With Gabapentin: A Placebo-Controlled Study
Pande, A. C., Davidson, J. R. T., Jefferson, J. W., Janney, C. A., Katzelnick, D. J., Weisler, R. H., Greist, J. H., & Sutherland, S. M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00010 · Cited by 395
Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release
Catterall, W. A. (1998) · Cell Calcium · doi:10.1016/s0143-4160(98)90055-0 · Cited by 386
Luo, Z. D., Calcutt, N. A., Higuera, E. S., Valder, C. R., Song, Y.-H., Svensson, C. I., & Myers, R. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041574 · Cited by 381
Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel
Saegusa, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2349 · Cited by 364
Peripheral Neuropathic Pain: From Mechanisms to Symptoms
Baron, R. (2000) · The Clinical Journal of Pain · doi:10.1097/00002508-200006001-00004 · Cited by 331
Lauria-Horner, B. A., & Pohl, R. B. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.663 · Cited by 327
Barclay, J., Balaguero, N., Mione, M., Ackerman, S. L., Letts, V. A., Brodbeck, J., Canti, C., Meir, A., Page, K. M., Kusumi, K., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06095.2001 · Cited by 326
Self-citationField, M. J., Oles, R. J., Lewis, A. S., McCleary, S., Hughes, J., & Singh, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701320 · Cited by 326
Self-citation3-Substituted GABA analogs with central nervous system activity: A review
Bryans, J. S., & Wustrow, D. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b · Cited by 297
Gurnett, C. A., De Waard, M., & Campbell, K. P. (1996) · Neuron · doi:10.1016/s0896-6273(00)80061-6 · Cited by 290
Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder
Pande, A. C., Pollack, M. H., Crockatt, J., Greiner, M., Chouinard, G., Lydiard, R. B., Taylor, C. B., Dager, S. R., & Shiovitz, T. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200008000-00011 · Cited by 279
An Overview of Neuropathic Pain: Syndromes, Symptoms, Signs, and Several Mechanisms
Dworkin, R. H. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200211000-00001 · Cited by 277
Gross, R. A., & Macdonald, R. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5469 · Cited by 264
Altered pain responses in mice lacking α 1E subunit of the voltage-dependent Ca 2+ channel
Saegusa, H., Kurihara, T., Zong, S., Minowa, O., Kazuno, A.-A., Han, W., Matsuda, Y., Yamanaka, H., Osanai, M., Noda, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100124197 · Cited by 229
Cantí, C., Nieto-Rostro, M., Foucault, I., Heblich, F., Wratten, J., Richards, M. W., Hendrich, J., Douglas, L., Page, K. M., Davies, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504183102 · Cited by 225
Self-citationField, M. J., Bramwell, S., Hughes, J., & Singh, L. (1999) · Pain · doi:10.1016/s0304-3959(99)00111-6 · Cited by 213
Self-citationStructure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein
Belliotti, T. R., Capiris, T., Ekhato, I. V., Kinsora, J. J., Field, M. J., Heffner, T. G., Meltzer, L. T., Schwarz, J. B., Taylor, C. P., Thorpe, A. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049762l · Cited by 212
Self-citationManeuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Calcium Channel α2δ Subunits: Differential Expression, Function, and Drug Binding
Klugbauer, N., Marais, E., & Hofmann, F. (2003) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000008028.41056.58 · Cited by 178
Davies, A., Douglas, L. R., Hendrich, J., Wratten, J., Tran-Van-Minh, A., Foucault, I., Koch, D., Pratt, W. S., Saibil, H. R., & DOLPHIN, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2764-06.2006 · Cited by 159
Self-citationLocalization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies
Hill, D. R., Suman‐Chauhan, N., & Woodruff, G. N. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90156-4 · Cited by 155
Structural requirement of the calcium-channel subunit α2δ for gabapentin binding
Wang, M., Offord, J., Oxender, D. L., & Su, T. (1999) · Biochemical Journal · doi:10.1042/bj3420313 · Cited by 129
Self-citationGabapentin is not a GABAB receptor agonist
Lanneau, C., Green, A., Hirst, W. D., Wise, A., Brown, J. T., Donnier, E., Charles, K. J., Wood, M. D., Davies, C. H., & Pangalos, M. N. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00140-x · Cited by 129
Transgenic Studies of Pain and Analgesia: Mutation or Background Genotype?
Lariviere, W. R., Chesler, E. J., & Mogil, J. S. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29558-6 · Cited by 118
Field, M. J., Hughes, J. M., & Singh, L. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703604 · Cited by 115
Self-citationPromoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes.
Swick, A. G., Janicot, M., Cheneval-Kastelic, T., McLenithan, J. C., & Lane, M. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1812 · Cited by 115
The Anticonvulsant Gabapentin (Neurontin) Does Not Act through γ-Aminobutyric Acid-B Receptors
Jensen, A. A., Mosbacher, J., Elg, S., Lingenhoehl, K., Lohmann, T., Johansen, T. N., Abrahamsen, B., Mattsson, J. P., Lehmann, A., Bettler, B., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1377 · Cited by 108
Construction of Gene Targeting Vectors from λKOS Genomic Libraries
Wattler, S., Kelly, M. D., & Nehls, M. C. (1999) · BioTechniques · doi:10.2144/99266rr02 · Cited by 98
Kato, J., Ogawa, S., Katz, J. D., Nagai, H., Kashiwazaki, M., Saeki, S., & Suzuki, H. (2000) · Clinical Journal of Pain · doi:10.1097/00002508-200003000-00003 · Cited by 97
Page, K. M., Heblich, F., Davies, A., Butcher, A. J., Leroy, J., Bertaso, F., Pratt, W. S., & Dolphin, A. C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0553-04.2004 · Cited by 94
Self-citationBertrand, S. S., Ng, G., Purisai, M. G., Wolfe, S. E., Severidt, M. W., Nouel, D., Robitaille, R., Low, M. J., O’Neill, G. P., Metters, K. M., et al. (2001) · PubMed · Cited by 92
Pain Perception in Mice Lacking the β3 Subunit of Voltage-activated Calcium Channels
Murakami, M., Fleischmann, B. K., Felipe, C. D., Freichel, M., Trost, C., Ludwig, A., Wissenbach, U., Schwegler, H., Hofmann, F. B., Hescheler, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203425200 · Cited by 84
Cloning and Deletion Mutagenesis of the α2δ Calcium Channel Subunit from Porcine Cerebral Cortex
Brown, J. P., & GEE, N. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25458 · Cited by 75
Bertrand, S. S., Ng, G., Purisai, M. G., Wolfe, S. E., Severidt, M. W., Nouel, D., Robitaille, R., Low, M. J., O’Neill, G. P., Metters, K. M., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29346-0 · Cited by 46
Selak, I. (2001) · PubMed · Cited by 8
Cited by
Zamponi, G. W., Striessnig, J., Koschak, A., & Dolphin, A. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009654 · Cited by 1,103
Self-citationNociceptors—Noxious Stimulus Detectors
Woolf, C. J., & Ma, Q. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.016 · Cited by 1,048
Eroglu, Ç., Allen, N. J., Susman, M. W., O'Rourke, N. A., Park, C. Y., Özkan, E., Chakraborty, C., Mulinyawe, S. B., Annis, D. S., Huberman, A. D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.025 · Cited by 893
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Bockbrader, H. N., Wesche, D., Miller, R., Chapel, S., Janiczek, N., & Burger, P. (2010) · Clinical Pharmacokinetics · doi:10.2165/11536200-000000000-00000 · Cited by 690
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Metadata
- Authors
- Field, M. J., Cox, P. J., Stott, E., Melrose, H., Offord, J., Su, T.-Z., Bramwell, S., Corradini, L., England, S., Winks, J., Kinloch, R. A., Hendrich, J., Dolphin, A. C., Webb, T., & Williams, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-11-14
- Volume
- 103
- Issue
- 46
- Pages
- 17537-17542
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1994334998
- Cited by
- 591
- References
- 44
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.